English   español  

Navegación por Autor Egea, Javier

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 11 a 25 de 25 < Anterior 
DerechosPreviewFecha Public.TítuloAutor(es)Tipo
closedAccessaccesoRestringido.pdf.jpg2017Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegenerationRamos, E.; Egea, Javier; Rios, C. de los; Marco-Contelles, José CSIC ORCID; Romero, A.artículo
closedAccessaccesoRestringido.pdf.jpg2017Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative DiseasesBautista-Aguilera, Óscar M. CSIC ORCID; Hagenow, S.; Palomino-Antolín, Alejandra; Farré-Alins, V.; Ismaili, L.; Joffrin, P. L.; Jimeno, M. Luisa CSIC ORCID; Soukup, Ondrej; Janockova, Jana; Kalinowski, A.; Proschak, E.; Iriepa, Isabel; Moraleda, I.; Schwed, J. S.; Romero Jódar, Alejandro CSIC ORCID; López-Muñoz, Francisco; Chioua, Mourad CSIC ORCID ; Egea, Javier; Ramsay, R. R.; Marco-Contelles, José CSIC ORCID; Stark, H.artículo
closedAccess2011N-Acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer’s diseaseGonzález Muñoz, Gema C.; Arce, Mariana P. CSIC; López, Beatriz; López, Beatriz; Romero Jódar, Alejandro CSIC ORCID; del Barrio, Laura; Martín de Saavedra, María Dolores; Egea, Javier; León, Rafael CSIC ORCID ; Villarroya, Mercedes; López, Manuela G.; García, Antonio G.; Conde, Santiago CSIC; Rodríguez-Franco, María Isabel CSIC ORCID artículo
openAccessWO2023037024A1.pdf.jpg16-mar-2023N-sulfonylurea derivatives and the therapeutic use thereofEgea, Javier; Narros-Fernández, Paloma; Cerrada-Gálvez, L.; Palomino-Antolín, Alejandra; Farré-Alins, V.; Decouty-Pérez, C.; López-Rodríguez, A. B. CSIC ORCID; Marco-Contelles, José CSIC ORCIDsolicitud de patente
openAccessnachain.pdf.jpg2020Na+ controls hypoxic signalling by the mitochondrial respiratory chainHernansanz-Agustín, Pablo; Choya-Foces, Carmen; Carregal-Romero, Susana; Ramos, Elena; Oliva, Tamara; Villa-Piña, Tamara; Moreno Capellán, Laura CSIC; Izquierdo-Álvarez, Alicia; Cabrera-García, J. Daniel; Cortés, Ana; Lechuga-Vieco, Ana V.; Jadiya, Pooja; Navarro, Elena; Parada, Esther; Palomino-Antolín, Alejandra; Tello, Daniel; Acín-Pérez, Rebeca; Rodríguez-Aguilera, Juan Carlos CSIC ORCID; Navas, Plácido CSIC ORCID; Cogolludo, Angel; López-Montero, Iván; Martínez-del-Pozo, Álvaro; Egea, Javier; López, Manuela G.; Elrod, John W.; Ruiz-Cabello, Jesús; Bogdanova, Anna; Enríquez, José Antonio; Martínez-Ruiz, Antonio CSIC ORCIDartículo
openAccessÁvilaJ_NeurotoxicityInducedbyOkadaic.pdf.jpg14-jun-2011Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by α7 and β2* nicotinic stimulationdel Barrio, Laura; Martín-de-Saavedra, María Dolores; Romero Jódar, Alejandro CSIC ORCID; Parada, Esther; Egea, Javier; Ávila, Jesús CSIC ORCID ; McIntosh, John Michael; Wonnacott, Susan; López, Manuela G.artículo
closedAccessaccesoRestringido.pdf.jpg2011Neurotoxicity Induced by Okadaic Acid in the Human Neuroblastoma SH-SY5Y Line Can Be Differentially Prevented by α7 and β2* Nicotinic StimulationBarrio, Laura del; Martín-de-Saavedra, María Dolores; Romero Jódar, Alejandro CSIC ORCID; Parada, Esther; Egea, Javier; Ávila, Jesús CSIC ORCID ; McIntosh, John Michael; Wonnacott, Susan; López, Manuela G.artículo
closedAccessaccesoRestringido.pdf.jpg2013Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemiaLorrio, Silvia; Gómez-Rangel, Vanessa; Negredo, Pilar; Egea, Javier; León, Rafael CSIC ORCID ; Romero Jódar, Alejandro CSIC ORCID; Dal-Cim, Tharine.; Villarroya, Mercedes; Rodríguez-Franco, María Isabel CSIC ORCID ; Conde, Santiago CSIC; Arce, Mariana P. CSIC; Roda, José María; García, Antonio G.; López, Manuela G.artículo
openAccessaccesoRestringido.pdf.jpg2015Novel tacrine-grafted ugi adducts as multipotent anti-alzheimer drugs: A synthetic renewal in tacrine-ferulic acid hybridsBenchekroun, Mohamed; Bartolini, Manuela; Egea, Javier; Romero Jódar, Alejandro CSIC ORCID; Soriano, Elena CSIC; Pudlo, M.; Luzet, Vincenza; Andrisano, V.; Jimeno, M. Luisa CSIC ORCID; López, M. G.; Wehle, S.; Gharbi, T.; Refouvelet, B.; Andrés, Lucía de CSIC; Herrera-Arozamena, Clara CSIC ORCID CVN; Monti, B.; Bolognesi, Maria Laura; Rodríguez-Franco, María Isabel CSIC ORCID ; Decker, Michael; Marco-Contelles, José CSIC ORCID; Ismaili, L.artículo
openAccessCadenasS_Nrf2PlaysaProtective.pdf.jpg3-jul-2019Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney InjuryRubio-Navarro, Alfonso; Vázquez-Carballo, Cristina; Guerrero-Hue, Melania; García-Caballero, Cristina; Herencia, Carmen; Gutiérrez, Eduardo; Yuste, Claudia; Sevillano, Ángel; Praga, Manuel; Egea, Javier; Cannata, Pablo; Cortegano, Isabel CSIC; Andrés, Belén de; Gaspar, María Luisa; Cadenas, Susana CSIC ORCID; Michalska, Patrycja; León, Rafael CSIC ORCID ; Ortiz, Alberto; Egido, Jesús; Moreno, Juan Antonioartículo
openAccesspharmaceuticals-14-00861-v2.pdf.jpg2021Privileged quinolylnitrones for the combined therapy of ischemic stroke and alzheimer’s diseaseAlonso, José M. CSIC; Escobar-Peso, Alejandro CSIC ORCID; Palomino-Antolín, Alejandra; Diez-Iriepa, Daniel CSIC; Chioua, Mourad CSIC ORCID ; Martínez-Alonso, E.; Iriepa, I.; Egea, Javier; Alcázar, Alberto; Marco-Contelles, José CSIC ORCIDartículo
openAccessmolecules-24-01503.pdf.jpg17-abr-2019QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease TherapyRamos, Eva; Palomino-Antolín, Alejandra; Bartolini, Manuela; Iriepa, Isabel; Moraleda, Ignacio; Diez-Iriepa, Daniel CSIC; Samadi, Abdelouahid CSIC ORCID; Cortina, Carol V.; Chioua, Mourad CSIC ORCID ; Egea, Javier; Romero Jódar, Alejandro CSIC ORCID; Marco-Contelles, José CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2022Synthesis and Pharmacological Evaluation of New N-Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat GoutNarros-Fernández, Paloma; Chioua, Mourad CSIC ORCID ; Petcu, Sonia A. CSIC; Diez-Iriepa, Daniel CSIC; Cerrada-Gálvez, L.; Decouty-Pérez, C.; Palomino-Antolín, Alejandra; Ramos, Eva; Farré-Alins, V.; López-Rodríguez, A. B. CSIC ORCID; Romero Jódar, Alejandro CSIC ORCID; Marco-Contelles, José CSIC ORCID; Egea, Javierartículo
closedAccessaccesoRestringido.pdf.jpg2016The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 ActivatorsBenchekroun, Mohamed; Romero Jódar, Alejandro CSIC ORCID; Egea, Javier; León, Rafael CSIC ORCID ; Michalska, P.; Buendía, I.; Jimeno, M. Luisa CSIC ORCID; Jun, Daniel; Janockova, Jana; Sepsova, V.; Soukup, Ondrej; Bautista-Aguilera, Óscar M. CSIC ORCID; Refouvelet, B.; Ouari, O.; Marco-Contelles, José CSIC ORCID; Ismaili, L.artículo
openAccessTLR4-pathway impairs synaptic number.pdf.jpg2021TLR4-pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injuryMartins Rosa, Juliana; Farré-Alins, V.; Ortega, M. C.; Navarrete, Marta CSIC ORCID ; López-Rodríguez, A. B. CSIC ORCID; Palomino-Antolín, Alejandra; Fernández-López, Elena; Vila-Del Sol, Virginia CSIC ORCID; Decouty, Céline; Narros-Fernández, Paloma; Clemente, Diego; Egea, Javierartículo